Anda di halaman 1dari 34

Department of Pharmacology

ANTIANGINA
Dr. M. Yulis Hamidy, M.Kes, M.Pd.Ked

Faculty of Medicine University of Riau

Department of Pharmacology

PATHOPHYSIOLOGY OF
ISCHEMIC HEART DISEASE
Angina pectoris, the primary symptom of ischemic
heart disease, is caused by transient episodes of
myocardial ischemia that are due to an imbalance in
the myocardial oxygen supplydemand relationship.
This imbalance may be caused by an increase in
myocardial oxygen demand (which is determined by
heart rate, ventricular contractility, and ventricular
wall tension) or by a decrease in myocardial oxygen
supply (primarily determined by coronary blood flow
but occasionally modified by the oxygen-carrying
capacity of the blood) or sometimes by both.
Faculty of Medicine University of Riau

Department of Pharmacology

ANGINAL SYMPTOMS
Typical angina is experienced as a heavy, pressing
substernal discomfort (rarely called "pain"), often
radiating to the left shoulder, flexor aspect of the left
arm, jaw, or epigastrium.
Women, the elderly, and diabetics are more likely to
have ischemia with atypical symptoms.
In most patients with typical angina, whose
symptoms are provoked by exertion, the symptoms
are relieved by rest or by administration of sublingual
nitroglycerin.
Faculty of Medicine University of Riau

Department of Pharmacology

Faculty of Medicine University of Riau

Department of Pharmacology

OBAT-OBAT ANTI ANGINA


NITRAT ORGANIK
-BLOKER
ANTAGONIS KALSIUM

Faculty of Medicine University of Riau

Department of Pharmacology

NITRAT ORGANIK

Faculty of Medicine University of Riau

Department of Pharmacology

KIMIA
NITRAT ORGANIK: ESTER ALKOHOL
POLIVALEN DENGAN ASAM NITRAT
NITRIT ORGANIK: ESTER ASAM
NITRAT & NITRIT
MUDAH LARUT DALAM LEMAK,
SEDANGKAN METABOLITNYA
LARUT DALAM AIR
Faculty of Medicine University of Riau

Department of Pharmacology

MEKANISME KERJA
Membentuk radikal bebas NO
guanilat siklase kadar siklik GMP otot
polos defosforilasi miosin
relaksasi otot polos

Faculty of Medicine University of Riau

Department of Pharmacology

FARMAKODINAMIK
EFEK KARDIOVASKULER

DOSIS RENDAH

TERUTAMA DILATASI VENA BESAR , DILATASI SEDIKIT PADA


ARTERIOL
RESISTENSI VASKULER SISTEMIK TETAP, RESISTENSI
VASKULER PARU & CO MENURUN, HR TETAP/NAIK SEDIKIT
FLUSHING
SAKIT KEPALA (DILATASI ARTERI MENINGEAL)

DOSIS TINGGI & PEMBERIAN CEPAT

VENODILATASI & DILATASI ARTERIOL PERIFER TEKANAN


DIASTOLIK & SISTOLIK , CURAH JANTUNG , FREKUENSI
JANTUNG (PUCAT, LEMAH, PUSING)

EFEK LAIN: RELAKSASI OTOT POLOS


(BRONKUS, SALURAN EMPEDU & SALURAN
CERNA) MANFAAT KLINIK (-)
Faculty of Medicine University of Riau

Department of Pharmacology

FARMAKOKINETIK
NITROGLISERIN SUBLINGUAL
KADAR PUNCAK 4 MENIT
WAKTU PARUH 1-3 MENIT
ISOSORBID DINITRAT SUBLINGUAL
KADAR MAKSIMUM DALAM 6 MENIT
WAKTU PARUH 45 MENIT
PADA PEMBERIAN ORAL METABOLISME DI
HATI
EKSKRESI MELALUI GINJAL

Faculty of Medicine University of Riau

Department of Pharmacology

SEDIAAN
SERANGAN AKUT SUBLINGUAL
MULA KERJA 1-2 MENIT
EFEK HILANG SETELAH 1 JAM

PENCEGAHAN ORAL
MULA KERJA LEMBAT
KADAR PUNCAK 60-90 MENIT
LAMA KERJA 3-6 JAM

VASOSPASME KORONER & ANGINA


TIDAK STABIL: IV
Faculty of Medicine University of Riau

Department of Pharmacology

SEDIAAN
SALEP
PROFILAKSIS
ABSORPSI MELALUI KULIT
EFEK TIMBUL DALAM 60 MENIT
BERAKHIR 4-8 JAM

DISC
EFEK TIMBUL DALAM 60 MENIT
BERAKHIR 4-8 JAM

SEDIAAN LEPAS LAMBAT


Faculty of Medicine University of Riau

Department of Pharmacology

Faculty of Medicine University of Riau

Department of Pharmacology

EFEK SAMPING
MERUPAKAN EFEK SEKUNDER SISTEM
KARDIOVASKULER
DAPAT TIMBUL TOLERANSI TERHADAP
EFEK TERAPI & EFEK SAMPING
DAPAT TIMBUL KETERGANTUNGAN
EDEMA PERIFER
DERMATITIS KONTAK (PEMBERIAN
TOPIKAL)
Faculty of Medicine University of Riau

Department of Pharmacology

PEMBERIAN HATI-HATI
1. PENINGKATAN TEKANAN INTRA
KRANIAL
2. HIPOTENSI BERAT
3. HIPOVOLEMIA YANG BELUM DIATASI
4. KARDIOMIOPATI HIPERTROFIK
5. STENOSIS AORTA
6. TAKIARITMIA

Faculty of Medicine University of Riau

Department of Pharmacology

KONTRA INDIKASI
PENDERITA YANG HIPERSENSITIF

Faculty of Medicine University of Riau

Department of Pharmacology

INDIKASI
1. ANGINA PEKTORIS
2. GAGAL JANTUNG KONGESTIF
3. INFARK JANTUNG

Faculty of Medicine University of Riau

Department of Pharmacology

BETA BLOKER

Faculty of Medicine University of Riau

Department of Pharmacology

MEKANISME KERJA
MENGURANGI KEBUTUHAN 02 MIOKARD
DENGAN MENURUNKAN FREKUENSI JANTUNG,
KONTRAKTILITAS MIOKARD & TEKANAN DARAH
DENGAN MENGHAMBAT ADRENOSEPTOR DI
JANTUNG SEWAKTU KERJA FISIK
2. MENINGKATKAN SUPLAI OKSIGEN MIOKARD
DENGAN MENURUNKAN TEGANGAN DINDING
VENTRIKEL SELAMA SISTOLE &
MEMPERLAMBAT DENYUT JANTUNG HINGGA
PERFUSI SUBENDOKARD MENINGKAT
1.

Faculty of Medicine University of Riau

Department of Pharmacology

EFEK SAMPING
KELANJUTAN EFEK FARMAKODINAMIK

BRADIKARDI
BLOK AV
GAGAL JANTUNG
BRONKOSPASME

BUKAN KELANJUTAN EFEK


FARMAKODINAMIK

SALURAN CERNA
EFEK SENTRAL
REAKSI ALERGI
Faculty of Medicine University of Riau

Department of Pharmacology

KONTRA INDIKASI

PENYAKIT PARU OBSTRUKTIF


DM YANG MUDAH MENGALAMI
HIPOGLIKEMIA PADA PEMBERIAN
ANTIDIABETIK
PENYAKIT VASKULER PERIFER YANG
BERAT
DISFUNGSI JANTUNG
BLOK AV
BRADIKARDI
Faculty of Medicine University of Riau

Department of Pharmacology

HATI-HATI PADA
1. DM YANG STABIL
2. PENYAKIT VASKULER RINGAN
3. GAGAL JANTUNG RINGAN
4. GANGGUAN KONDUKSI JANTUNG

Faculty of Medicine University of Riau

Department of Pharmacology

ANTAGONIS KALSIUM

Faculty of Medicine University of Riau

Department of Pharmacology

MEKANISME KERJA
- MENGHAMBAT MASUKNYA ION Ca2+
MELEWATI SLOW CHANNEL YANG
TERDAPAT PADA MEMBRAN SEL
- EFEK KRONOTROPIK DAN INOTROPIK
NEGATIF, KARENA TERHAMBATNYA
ARUS MASUK ION Ca2+ KE DALAM SEL
JANTUNG

Faculty of Medicine University of Riau

Department of Pharmacology

MEKANISME ANTIANGINA
MENGURANGI KEBUTUHAN OKSIGEN
MIOKARDIUM MELALUI:
1.

2.
3.

VASODILATASI PERIFER (TERUTAMA


ARTERIOL), MENURUNKAN AFTER
LOAD (N>V>D)
PENGURANGAN KONTRAKTILITAS
MIOKARD (V>D)
PENURUNAN FREKUENSI DENYUT
JANTUNG (D>V)
Faculty of Medicine University of Riau

Department of Pharmacology

MEKANISME ANTIANGINA
MENINGKATKAN SUPLAI OKSIGEN MIOKARD MELALUI:
1. DILATASI LANGSUNG ARTERI EPIKARDIAL (N>D>V)
SEHINGGA DAPAT MENGATASI/MENCEGAH VASOSPASME
KORONER PADA ANGINA VASOSPASTIK
2. PENURUNAN TEKANAN DARAH (N>V>D), TEGANGAN
DINDING VENTRIKEL SELAMA SISTOLE BERKURANG
AKIBATNYA PERFUSI SUBENDOKARD
3. DILATASI ARTERI EPIKARDIAL
4. DILATASI STENOSIS EKSENTRIS PADA ARTERI
EPIKARDIAL, MENINGKATKAN ALIRAN DARAH DI
DAERAH ISKEMIK
5. PENURUNAN DENYUT JANTUNG (D>V)
6. MEMPERPANJANG WAKTU DIASTOLIK
MENINGKATKAN PERFUSI MIOKARD
Faculty of Medicine University of Riau

Department of Pharmacology

KLASIFIKASI
DIHIDROPIRIDIN (DHP): NIFEDIPIN,
NIKARDIPIN, FELODIPIN, AMLODIPIN
DIFENILALKILAMIN: VERAPAMIL,
GALOPAMIL, TIAPAMIL
BENZOTIAZEPIN: DILTIAZEM
PIPERAZIN: SINARIZIN, FLUNARIZIN
LAIN-LAIN: PRENILAMIN, PERHEKSILIN
MENGHAMBAT SECARA SELEKTIF KANAL Ca2+
MENGHAMBAT KANAL Ca2+ DAN KANAL Na+
Faculty of Medicine University of Riau

Department of Pharmacology

EFEK SAMPING

VASODILATASI BERLEBIHAN
NYERI KEPALA BERDENYUT
PUSING
MUKA MERAH
EDEMA PERIPER
HIPOTENSI
REFLEKS TAKIKARDI
PALPITASI

EFEK INOTROPIK NEGATIF GAGAL


JANTUNG
Faculty of Medicine University of Riau

Department of Pharmacology

Faculty of Medicine University of Riau

Department of Pharmacology

Faculty of Medicine University of Riau

Department of Pharmacology

PENGGUNAAN KLINIK
1. ANGINA STABIL KRONIK

Serangan jarang nitrat kerja singkat


Serangan sering:
Tahap I monoterapi (nitrat kerja lama, bloker atau
CCB)
Tahap II kombinasi 2 obat
Nitrat kerja lama + CCB
bloker + CCB
Tahap III kombinasi 3 obat (nitrat kerja lama+
bloker + CCB)
Faculty of Medicine University of Riau

Department of Pharmacology

PENGGUNAAN KLINIK
2. ANGINA VARIAN
Pilih penghambat vasospasme kuat (nitrat &
CCB)
Terapi jangka panjang (CCB)
Tahap I
Tahap II
Tahap III
Tahap IV

: monoterapi, salah satu CCB


: tahap I + nitrat kerja lama
: = tahap II, jenis CCB diganti
: kombinasi 2 CCB (N+V atau N+D)

Faculty of Medicine University of Riau

Department of Pharmacology

PENGGUNAAN KLINIK
3. ANGINA TAK STABIL

TAHAP I: DIRAWAT DI RS

NITRAT SUBLINGUAL ORAL IV


HASIL MASIH KURANG TAMBAHKAN + CCB ATAU
BLOKER
HASIL TERBAIK KOMBINASI NITRAT + CCB + BLOKER
(TRIPLE THERAPY)

TAHAP II: LAKUKAN ARTERIOGRAFI KORONER


UNTUK DAPAT DITETAPKAN
PENATALAKSANAAN YANG OPTIMAL
TAHAP III: TROMBOLITIK, ANGIOPLASTI ATAU
BEDAH PINTAS KORONER
Faculty of Medicine University of Riau

Department of Pharmacology

Faculty of Medicine University of Riau

Anda mungkin juga menyukai